Lillian Lunkuse
Biographic Data
| ID | 2528731 |
|---|---|
| NAME | Lillian Lunkuse |
| GIVEN NAMES | Lillian |
| FAMILY NAME | Lunkuse |
| SIGNATURE | LUNKUSE L |
| AFFILIATIONS | Mildmay Uganda |
| ORCID | 0000-0001-5485-4966 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Barriers and facilitators of antiretroviral therapy (ART) adherence habit formation in Sub-Saharan Africa
The role of material deprivations in determining ART adherence
Despite sustained global scale-up of antiretroviral therapy (ART), adherence to ART remains low. Less than half of those in HIV care in Uganda achieve 85% adherence to their ART medication required for clinically meaningful viral suppression, leaving them at higher risk of transmission. Key barriers to ART adherence include poverty-related structural barriers that are inter-connected and occur simultaneously, making it challenging to examine and …
The one who doesn’t take ART medication has no wealth at all and no purpose on Earth” – a qualitative assessment of how HIV-positive adults in Uganda understand the health and wealth-related benefits …
PLWH consider short and long-term health benefits of ART. Programming designed to shape ART uptake and increase adherence should emphasize the broader benefits of ART at various levels. Having such benefits directly integrated into the design of clinic-based HIV interventions can be useful especially for PLWH who face competing interests to increase medication adherence. These benefits can ultimately help providers and policymakers better underst…
No prominent works on this page.
The role of material deprivations in determining ART adherence
Despite sustained global scale-up of antiretroviral therapy (ART), adherence to ART remains low. Less than half of those in HIV care in Uganda achieve 85% adherence to their ART medication required for clinically meaningful viral suppression, leaving them at higher risk of transmission. Key barriers to ART adherence include poverty-related structural barriers that are inter-connected and occur simultaneously, making it challenging to examine and …
The one who doesn’t take ART medication has no wealth at all and no purpose on Earth” – a qualitative assessment of how HIV-positive adults in Uganda understand the health and wealth-related benefits …
PLWH consider short and long-term health benefits of ART. Programming designed to shape ART uptake and increase adherence should emphasize the broader benefits of ART at various levels. Having such benefits directly integrated into the design of clinic-based HIV interventions can be useful especially for PLWH who face competing interests to increase medication adherence. These benefits can ultimately help providers and policymakers better underst…
Barriers and facilitators of antiretroviral therapy (ART) adherence habit formation in Sub-Saharan Africa
Environmental health (3 works) · Family medicine (3 works) · HIV/AIDS Research and Interventions (3 works) · Medicine (3 works) · Nursing (3 works) · Psychology (3 works) · Economic growth (2 works) · HIV, Drug Use, Sexual Risk (2 works) · Population (2 works) · Qualitative research (2 works)